Emerging Technologies
The open-source gene editor is freely available to license for commercial use and ethical research.
Vibhor Gupta, founder of Pangaea Data, talks about how artificial intelligence can bridge gaps in hard-to-diagnose conditions in the National Health Service's cancer patients.
The pharma giant's employees will have access to ChatGPT Enterprise, which allows teams to create customized GPTs on specific topics.
Epitel received 510(k) clearance for two remote monitoring offerings and Curio Digital Therapeutics received clearance for its postpartum prescription digital therapeutic.
The ODU-led team will assess the commercial viability and feasibility of digital environments for people who are visually impaired.
Xaira's CEO, Dr. Marc Tessier-Lavigne, resigned as president of Stanford University last August due to controversy over inaccuracies discovered in his lab's scientific papers.
The health insurance company will expand its use of Cohere's prior authorization platform to include diagnostic imaging and sleep services.
The Home as a Health Care Hub will use augmented and virtual reality to reimagine how the home can become a system that improves health equity.
The proof-of-concept study published in Nature Cancer highlights how researchers are using tumor cells to predict whether patients will respond to specific drugs.
HIMSS24
Punit Soni, Suki AI CEO and founder, discusses how his company's integration of its AI assistant with Amwell's Converge telehealth platform to generate clinical notes and coding has reduced doctors' workload by up to 75% and boosted job satisfaction.